News
Neoantigen Summit Europe, 20 – 22 April 2021
Our CEO, Gerben Zondag will present Immunetune's unique platform AmpliVax that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming digital Neoantigen Summit Europe on 20-22 Apri...
Bio-Europe Spring, 22-25 March 2021
We will attend the digital Bio-Europe Spring patnering meeting on 22 – 25 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Sachs Associates EU Life Sciences CEO Forum, 10 -11 March 2021
We will attend the digital Sachs Associates 14th European Life Sciences CEO Forum on 10-11 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Neoantigen Summit Europe, 20 – 22 April 2021
Our CEO, Gerben Zondag will present Immunetune's unique platform AmpliVax that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming digital Neoantigen Summit Europe on 20-22 Apri...
Bio-Europe Spring, 22-25 March 2021
We will attend the digital Bio-Europe Spring patnering meeting on 22 – 25 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Sachs Associates EU Life Sciences CEO Forum, 10 -11 March 2021
We will attend the digital Sachs Associates 14th European Life Sciences CEO Forum on 10-11 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Important Regulatory Milestone achieved for Immunetune’s NeoVAC platform
Immunetune is proud to announce that they can continue their regulatory pathway, following supportive Scientific Advice from the Paul-Ehrlich Institute (PEI) in Germany on the 18th of June 2020. “The overall positive feedback received from the renowned...